SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-20-000821
Filing Date
2020-02-07
Accepted
2020-02-07 16:09:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 DYNAVAX TECHNOLOGIES CORPORATION p20-0238sc13ga.htm SC 13G/A 61663
  Complete submission text file 0000902664-20-000821.txt   63386
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80035 | Film No.: 20587495
SIC: 2834 Pharmaceutical Preparations

Mailing Address 540 MADISON AVENUE 32ND FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 32ND FLOOR NEW YORK NY 10022 514-281-8082
Senvest Management, LLC (Filed by) CIK: 0001328785 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A